Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can monthly Check-Ins boost pain relief from talk therapy?

NCT ID NCT04680000

Symptom relief Sponsor: The University of Texas Health Science Center at San Antonio Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jul 01, 2026 · Updated 3 times

Summary

This study tests whether adding monthly booster sessions to standard cognitive behavioral therapy (CBT) helps people with chronic pain manage their symptoms better over 18 months. About 716 military health system beneficiaries with chronic pain will receive either standard CBT or CBT with monthly boosters. Researchers will track changes in pain intensity and mental health to see if the extra sessions make a lasting difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Brief Cognitive Behavioral Therapy for Chronic Pain (BCBT-CP)
What this could lead to
If it works, this could show that monthly booster sessions help people with chronic pain maintain better pain control and mental health over the long term.
What could go wrong
This is a pragmatic trial testing an existing therapy, not a new drug or cure. Results may not apply to all chronic pain patients, and the benefit of boosters may be small or absent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 716 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2021

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. DoD/MHS beneficiary (including active duty service members, veterans, and family members) age 18 and older. 2. Presenting with a chronic pain complaint (pain occurring more days than not over the past three months that is ongoing at the time of baseline evaluation). 3. Referred for BCBT-CP with a BHC by a Primary Care provider. 4. Speaks and reads/understands English well enough to fully participate in the intervention and to reliably complete assessment measures. Exclusion Criteria: 1. Scheduled for a planned pain-related surgery or pain intervention within 6 weeks of enrollment (because the intervention may obscure BCBT-CP outcomes). 2. Inability or unwillingness of individual to give written informed consent. 3. Experiencing another health problem of higher priority for care or that prohibits ability to attend BCBT-CP or research appointments. Some research activities (i.e., Focus Groups) will include Clinic Providers and Staff: Inclusion Criteria for Clinic Provider/Staff Participants 1. BHC trained to deliver care according to the Chronic Pain Clinical Pathway 2. Clinic providers/staff caring for patient participants enrolled in this study Exclusion Criteria for Clinic Provider/Staff Participants: none

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Pain chronic pain syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic pain

Contacts and locations

Locations

  • Brooke Army Medical Center

    San Antonio, Texas, 78257, United States

  • Fort Cavazos

    Fort Hood, Texas, 76544, United States

  • Uniformed Services University for the Health Sciences

    Bethesda, Maryland, 20814, United States

  • University of Texas Health Science Center San Antonio

    San Antonio, Texas, 78229, United States

  • Wilford Hall Ambulatory Surgical Center

    San Antonio, Texas, 78236-9908, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.